This week's funding deals (Dec 14–20) spotlighted several innovative startups across various industries, raising significant capital to fuel their growth.
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ...
Someday, we may have the technology to put all the deterministic rules and logic that constitute an application today into a nondeterministic ... Firms are thinking differently about organizing around ...